FDA Inspection 1013356 — Oklahoma Blood Institute Norman Center
The FDA completed an inspection of Oklahoma Blood Institute Norman Center on May 25, 2017 in Norman, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 25, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Norman, OK (United States)